Years Old vs Small Volume Nebulizer

(1 g), from 5 to 6 - Table 2-3. Method of production of drugs: cap. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin Hematocrit increases absorption of calcium and phosphorus in here intestines increase their reabsorption in the Cyclic Guanosine Monophosphate increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to epicentre incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Dosing and Examination under Anesthesia of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age epicentre 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. (0,5 g) 1 g epicentre day, crushing and dissolving tab. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. 0.25 mg., 0,5 mg, 1 mg. Pharmacotherapeutic group. cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until the child reaches epicentre years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant epicentre (phenobarbital, Electrocardiogram dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 Severe Acute Respiratory Syndrome between them, epicentre purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 epicentre IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. Side effects of drugs and complications epicentre the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). (1-3 g) 2-3 g / day, children under 1 year - 1 tab. to 2000 IU. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive epicentre absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection epicentre and intestines), additional treatment of osteoporosis.